| David A Sherris, MD | |
|
1237 Delaware Ave, Buffalo, NY 14209-1435 | |
| (716) 884-5102 | |
| (716) 884-5104 |
| Full Name | David A Sherris |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 1237 Delaware Ave, Buffalo, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689646739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 178951-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sisters Of Charity Hospital | Buffalo, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University At Buffalo Otolaryngology, Inc | 5991692402 | 2 |
News Archive
Scientists have identified genetic mutations that appear to be a key culprit behind a suite of birth defects called ciliopathies, which affect an estimated 1 in 1,000 births.
Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use.
A common transmissible strain of the bacteria Pseudomonas aeruginosa has been identified among cystic fibrosis (CF) patients in Canada, suggesting that cross-infection has occurred widely between CF centers in the United Kingdom and Canada, according to a study in the November 17 issue of JAMA. Infection with this strain among Canadian CF patients has been associated with an increased risk of death or lung transplantation.
Galapagos NV (Euronext: GLPG) announced today that it has initiated clinical Phase I development of the first small molecule candidate from its arthritis alliance with GlaxoSmithKline (GSK).
› Verified 9 days ago
| Entity Name | University At Buffalo Otolaryngology, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447320593 PECOS PAC ID: 5991692402 Enrollment ID: O20040301000495 |
News Archive
Scientists have identified genetic mutations that appear to be a key culprit behind a suite of birth defects called ciliopathies, which affect an estimated 1 in 1,000 births.
Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use.
A common transmissible strain of the bacteria Pseudomonas aeruginosa has been identified among cystic fibrosis (CF) patients in Canada, suggesting that cross-infection has occurred widely between CF centers in the United Kingdom and Canada, according to a study in the November 17 issue of JAMA. Infection with this strain among Canadian CF patients has been associated with an increased risk of death or lung transplantation.
Galapagos NV (Euronext: GLPG) announced today that it has initiated clinical Phase I development of the first small molecule candidate from its arthritis alliance with GlaxoSmithKline (GSK).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Sherris, MD 1237 Delaware Ave, Buffalo, NY 14209-1435 Ph: (716) 884-5102 | David A Sherris, MD 1237 Delaware Ave, Buffalo, NY 14209-1435 Ph: (716) 884-5102 |
News Archive
Scientists have identified genetic mutations that appear to be a key culprit behind a suite of birth defects called ciliopathies, which affect an estimated 1 in 1,000 births.
Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use.
A common transmissible strain of the bacteria Pseudomonas aeruginosa has been identified among cystic fibrosis (CF) patients in Canada, suggesting that cross-infection has occurred widely between CF centers in the United Kingdom and Canada, according to a study in the November 17 issue of JAMA. Infection with this strain among Canadian CF patients has been associated with an increased risk of death or lung transplantation.
Galapagos NV (Euronext: GLPG) announced today that it has initiated clinical Phase I development of the first small molecule candidate from its arthritis alliance with GlaxoSmithKline (GSK).
› Verified 9 days ago
Dr. Philomena M Behar, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 219 Bryant St, Buffalo, NY 14222 Phone: 716-878-7569 Fax: 716-878-7585 | |
Carolyn Marie Cormier, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1083 Delaware Ave, Buffalo, NY 14209 Phone: 716-882-1023 | |
Dr. Jon Michael Chan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 65 Oakland Pl, Buffalo, NY 14222 Phone: 614-366-3687 | |
Vincent P Callanan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 219 Bryant St, Buffalo, NY 14222 Phone: 716-878-7368 Fax: 716-878-1234 | |
Kien Thuan Le, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 100 High St, Buffalo, NY 14203 Phone: 716-859-5600 | |
Dr. Ryan Patrick Mcspadden, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 | |
Ayham Al Afif, MD, MSC. FRSCS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-3158 Fax: 716-845-8646 |